SCHEMBL29821674

SCHEMBL29821674

O=c1ccc(Oc2c(Br)cc([N+](=O)[O-])cc2Br)cn1Cc1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ MAPT P10636 3/20 0.40
▸ LMNA P02545 2/20 0.40
▸ CASP1 P29466 1/20 0.40
▸ CASP3 P42574 1/20 0.40
▸ CASP4 P49662 1/20 0.40
▸ CASP7 P55210 1/20 0.40
▸ CASP9 P55211 1/20 0.40
▸ CASP6 P55212 1/20 0.40
▸ CASP8 Q14790 1/20 0.40
▸ MGLL Q99685 3/20 0.39
▸ ABHD6 Q9BV23 1/20 0.39
▸ CYP19A1 P11511 1/20 0.39
▸ POLB P06746 1/20 0.38
▸ APOBEC3G Q9HC16 1/20 0.38
▸ CA12 O43570 1/20 0.38
▸ CA9 Q16790 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.37
▸ KDM4E B2RXH2 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29821636 0.87 HTT (0.40) MEN1KMT2AMAPTCASP1CASP3
SCHEMBL29821964 0.86 P2RX7 (0.43) MEN1KMT2AMAPTLMNACYP19A1
SCHEMBL23168957 0.84 MEN1 (0.44) MEN1KMT2AMGLLABHD6ALDH1A1
SCHEMBL29821659 0.76 POLB (0.40) MAPTLMNACYP19A1POLBALDH1A1
SCHEMBL5925051 0.76 KMT2A (0.48) MEN1KMT2AMAPTLMNACASP1
SCHEMBL24820993 0.75 MKNK1 (0.42) MEN1KMT2AMAPTALDH1A1BRD4
SCHEMBL23168794 0.74 HPGD (0.43) MEN1KMT2AALDH1A1SMN1; SMN2BRD4
SCHEMBL8808397 0.72 MAPT (0.60) MEN1KMT2AMAPTLMNACYP19A1
SCHEMBL5435679 0.70 PGR (0.58) MEN1KMT2AMAPTLMNAALDH1A1
SCHEMBL18764602 0.69 ALDH1A1 (0.56) MEN1KMT2AMAPTLMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12617769-B2 Chemical compound as thyroid hormone beta receptor agonist and use thereof SUNSHINE LAKE PHARMA CO., LTD. (CN) 2026-05-05 — — US disclosed
US-20220411400-A1 CHEMICAL COMPOUND AS THYROID HORMONE BETA RECEPTOR AGONIST AND USE THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2022-12-29 — — US disclosed
EP-4036090-A1 CHEMICAL COMPOUND AS THYROID HORMONE BETA RECEPTOR AGONIST AND USE THEREOF Sunshine Lake Pharma Co., Ltd. (CN) 2022-08-03 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411400-A1 CHEMICAL COMPOUND AS THYROID HORMONE BETA RECEPTOR AGONIST AND USE THEREOF THRB, TSHR, THRA MEN1 891/4885KMT2A 2737/4885MAPT 1873/4885
US-12617769-B2 Chemical compound as thyroid hormone beta receptor agonist and use thereof THRB, TSHR, THRA MEN1 2442/4885KMT2A 4017/4885MAPT 2264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback